Human Vaccines & Immunotherapeutics: News

Mostrar otras versiones (9)

Agenus reports increased survival rates for its brain cancer vaccine First vaccines developed for avian influenza A H7N9 virus Ovarian cancer vaccine shows promise in early clinical trial  No increased risk of GBS following vaccination Heroin vaccine blocks relapse in animal study New pediatric vacc...

Descripción completa

Detalles Bibliográficos
Autor principal: Riedmann, Eva M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Editor's Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901805/
http://dx.doi.org/10.4161/hv.25576
_version_ 1782300909193134080
author Riedmann, Eva M.
author_facet Riedmann, Eva M.
author_sort Riedmann, Eva M.
collection PubMed
description Agenus reports increased survival rates for its brain cancer vaccine First vaccines developed for avian influenza A H7N9 virus Ovarian cancer vaccine shows promise in early clinical trial  No increased risk of GBS following vaccination Heroin vaccine blocks relapse in animal study New pediatric vaccine approved in Europe Safe antigen delivery: Engineered type-III secretion system in bacterial mini-cells Universal influenza T-cell vaccine effective in an elderly population
format Online
Article
Text
id pubmed-3901805
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-39018052014-03-10 Human Vaccines & Immunotherapeutics: News Riedmann, Eva M. Hum Vaccin Immunother Editor's Corner Agenus reports increased survival rates for its brain cancer vaccine First vaccines developed for avian influenza A H7N9 virus Ovarian cancer vaccine shows promise in early clinical trial  No increased risk of GBS following vaccination Heroin vaccine blocks relapse in animal study New pediatric vaccine approved in Europe Safe antigen delivery: Engineered type-III secretion system in bacterial mini-cells Universal influenza T-cell vaccine effective in an elderly population Landes Bioscience 2013-06-01 2013-10-16 /pmc/articles/PMC3901805/ http://dx.doi.org/10.4161/hv.25576 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Editor's Corner
Riedmann, Eva M.
Human Vaccines & Immunotherapeutics: News
title Human Vaccines & Immunotherapeutics: News
title_full Human Vaccines & Immunotherapeutics: News
title_fullStr Human Vaccines & Immunotherapeutics: News
title_full_unstemmed Human Vaccines & Immunotherapeutics: News
title_short Human Vaccines & Immunotherapeutics: News
title_sort human vaccines & immunotherapeutics: news
topic Editor's Corner
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901805/
http://dx.doi.org/10.4161/hv.25576
work_keys_str_mv AT riedmannevam humanvaccinesimmunotherapeuticsnews

Ejemplares similares